For citations:
Vasilkova V.N., Pchelin I.Yu., Bayrasheva V.K., Borovets Ya.A., Yarets Yu.I., Navmenova Ya.L., Naumenka E.P., Mokhort T.V. Cardioprotective effects of empagliflosin and vildagliptin: clinical and instrumental assessment of structural and functional parameters of the heart and cardiac markers in patients with diabetes type 2. Medical and Biological Problems of Life Activity. 2021;(2):91-98. (In Russ.)
Email this article 